Peter Sieger
40Patents
13h-index
45Co-inventors
81Inventor score
Filing activity: Mar 26, 1999 → Jun 30, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6777423B2 | Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions | Chemistry; Metallurgy | 71 | Expired |
| US8106060B2 | 8-(3-amino-piperidin-1-yl)-xanthines, their preparation, and their use as pharmaceuticals | Human Necessities | 67 | Active |
| US6908928B2 | Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions | Chemistry; Metallurgy | 55 | Expired |
| US8865729B2 | Salt forms of a xanthine compound | Chemistry; Metallurgy | 44 | Active |
| US9212183B2 | Salt forms of 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(R)-amino-piperidin-1-yl)-xanthine | Chemistry; Metallurgy | 33 | Active |
| US9266888B2 | Polymorphs | Chemistry; Metallurgy | 28 | Active |
| US8637530B2 | 8-(3-amino-piperidin-1-yl)-xanthines, their preparation, and their use as pharmaceuticals | Human Necessities | 28 | Active |
| US7439358B2 | Specific salt, anhydrous and crystalline form of a dihydropteridione derivative | Human Necessities | 27 | Active |
| US7728134B2 | Hydrates and polymorphs of 4[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament | Chemistry; Metallurgy | 19 | Expired |
| US7119093B2 | 3-Z-[1-(4-(N-((4-Methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate and the use thereof as a pharmaceutical composition | Human Necessities | 19 | Expired |
| US6869948B1 | Meloxicam for oral administration | Human Necessities | 18 | Expired |
| US6608055B2 | Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition | Chemistry; Metallurgy | 16 | Expired |
| US7932273B2 | 3-[(2-{[4-(hexyloxycarbonylaminoiminomethyl) phenylamino]methyl}-1-methyl-1H-benzimidazol-5-carbonyl)pyridin-2-ylamino]propionic acid ethylester methansulfonate and its use as a medicament | Human Necessities | 16 | Active |
| US10301313B2 | Polymorphs | Chemistry; Metallurgy | 12 | Active |
| US7220742B2 | Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments | Chemistry; Metallurgy | 11 | Expired |
| US9493462B2 | Polymorphs | Chemistry; Metallurgy | 11 | Active |
| US9815837B2 | Polymorphs | Chemistry; Metallurgy | 11 | Active |
| US8426586B2 | Process for preparing amino crotonyl compounds | Human Necessities | 9 | Active |
| US8034816B2 | Hydrates and polymorphs of 4-[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament | Chemistry; Metallurgy | 9 | Active |
| US8202867B2 | Methods of using hydrates and polymorphs of 4-[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide | Chemistry; Metallurgy | 8 | Active |
| US8188086B2 | Specific salt, anhydrous and crystalline form of a dihydropteridione derivative | Human Necessities | 8 | Active |
| US8329695B2 | Crystalline form of the free base N-[trans-4-[4-(cyclopropylmethyl)-1-piperazinyl]cyclohexyl]-4-[[(7r)-7-ethyl-5,6,7,8-tetrahydro-5-methyl-8-(1-methylethyl)-6-oxo-2-pteridinyl]amino]-3-methoxy-benzamide | Human Necessities | 7 | Active |
| US7491719B2 | Enantiomerically pure beta agonists, process for the manufacture thereof, and use thereof as medicaments | Chemistry; Metallurgy | 6 | Active |
| US7968717B2 | Crystalline anhydrate with anticholinergic efficacy | Chemistry; Metallurgy | 4 | Active |
| US7534789B2 | Enantiomeric pure β agonists, manufacturing and use as a medicament thereof | Human Necessities | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.